Class 2 Medicines : Norgine Pharmaceuticals Limited, Pedmarqsi 80
OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 4 Medicines Defect Notification: Fresenius Medical Care Recall: Fresenius Medical Care Deutschland
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CountryUnited KingdomPublishedMay 14, 2026Last updatedMay 14, 2026Official source last checkedSeptember 9, 2026 at 1:48 PM UTC
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24
- Manufacturer
- See official notice
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label.
Hazard
Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label.
What consumers should do
for Healthcare Professionals: There is no product quality issue, the affected batches will not be recalled. Where necessary, healthcare professionals should explain the Braille text error to patients who depend solely on braille for reading medicine packaging. Advice for Patients: Patients can continue using solution bags from the above batches, and no further action is required. Any required support or guidance will be provided by the relevant healthcare professionals. Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme . Additional information: For all medical information enquiries and information on this product, please email Medinfo-UK@freseniusmedicalcare.com , or telephone 01623 445 215. For stock control enquiries please email ukorders@freseniusmedicalcare.com , or telephone 01623 445 100. Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to share this with Nephrologists & Renal Nurse practitioners for information. Yours faith
Official recall notice
Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: May 14, 2026
Read the official UK_MHRA recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
